Drug information for NEXIUM IV
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INTRAVENOUS
EQ 20MG BASE/VIAL
Prescription
(Reference Drug)
ESOMEPRAZOLE SODIUM
Omeprazole
ASTRAZENECA
21689
2012-01-24 Label
2012-01-24 Letter
2011-12-20 Other Important Information from FDA
2011-07-06 Label
2011-07-06 Letter
2011-06-29 Label
2011-06-27 Letter
2011-05-04 Letter
2011-04-29 Label
2010-09-10 Label
2010-09-08 Letter
2010-03-08 Letter
2010-03-05 Label
2009-01-21 Letter
2009-01-21 Letter
2009-01-16 Label
2009-01-16 Label
2007-08-06 Review
2007-05-01 Letter
2007-05-01 Label
2007-05-01 Label
2006-10-02 Letter
2006-09-27 Label
2006-09-20 Letter
2006-09-18 Label
2006-03-01 Letter
2006-02-22 Label
2006-01-20 Letter
2006-01-13 Label
2005-04-06 Label
2005-04-06 Letter
INJECTABLE; INTRAVENOUS
EQ 40MG BASE/VIAL
Prescription
(Reference Drug)
ESOMEPRAZOLE SODIUM
Omeprazole
ASTRAZENECA
"
Drug Adverse Effects information for NEXIUM IV
Role code
Indications
Reaction
# Reports
C
HYPONATRAEMIA
POLYURIA
1
C
HYPONATRAEMIA
RAPID CORRECTION OF HYPONATRAEMIA
1
C
OSTEOPOROSIS
BONE CALLUS EXCESSIVE
1
C
OSTEOPOROSIS
BONE DISORDER
1
C
OSTEOPOROSIS
COLLAGEN DISORDER
1
C
OSTEOPOROSIS
DISEASE RECURRENCE
1
C
OSTEOPOROSIS
FALL
1
C
OSTEOPOROSIS
FEMUR FRACTURE
1
C
OSTEOPOROSIS
FOOT FRACTURE
1
C
OSTEOPOROSIS
FRACTURE DELAYED UNION
1
C
OSTEOPOROSIS
FRACTURE DISPLACEMENT
1
C
OSTEOPOROSIS
FRACTURE NONUNION
1
C
OSTEOPOROSIS
HYPERPARATHYROIDISM
1
C
OSTEOPOROSIS
METASTASES TO BONE
1
C
OSTEOPOROSIS
OSTEOCHONDROSIS
1
C
OSTEOPOROSIS
OSTEOGENESIS IMPERFECTA
1
C
OSTEOPOROSIS
PAIN IN EXTREMITY
1
C
OSTEOPOROSIS
SPINAL COMPRESSION FRACTURE
1
C
OSTEOPOROSIS
STRESS FRACTURE
1
Ads by Google